85 related articles for article (PubMed ID: 19477270)
1. Interaction of the ubiquitin carboxyl terminal esterase L1 with alpha(2)-adrenergic receptors inhibits agonist-mediated p44/42 MAP kinase activation.
Weber B; Schaper C; Wang Y; Scholz J; Bein B
Cell Signal; 2009 Oct; 21(10):1513-21. PubMed ID: 19477270
[TBL] [Abstract][Full Text] [Related]
2. Alpha2A- and alpha2C-adrenergic receptors form homo- and heterodimers: the heterodimeric state impairs agonist-promoted GRK phosphorylation and beta-arrestin recruitment.
Small KM; Schwarb MR; Glinka C; Theiss CT; Brown KM; Seman CA; Liggett SB
Biochemistry; 2006 Apr; 45(15):4760-7. PubMed ID: 16605244
[TBL] [Abstract][Full Text] [Related]
3. alpha 2A/alpha 2C-adrenergic receptor third loop chimera show that agonist interaction with receptor subtype backbone establishes G protein-coupled receptor kinase phosphorylation.
Jewell-Motz EA; Small KM; Theiss CT; Liggett SB
J Biol Chem; 2000 Sep; 275(37):28989-93. PubMed ID: 10893245
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin C-terminal hydrolase UCH-L1 promotes bacterial invasion by altering the dynamics of the actin cytoskeleton.
Bassères E; Coppotelli G; Pfirrmann T; Andersen JB; Masucci M; Frisan T
Cell Microbiol; 2010 Nov; 12(11):1622-33. PubMed ID: 20608941
[TBL] [Abstract][Full Text] [Related]
5. Regulation of α(2B)-adrenergic receptor-mediated extracellular signal-regulated kinase 1/2 (ERK1/2) activation by ADP-ribosylation factor 1.
Dong C; Li C; Wu G
J Biol Chem; 2011 Dec; 286(50):43361-9. PubMed ID: 22025613
[TBL] [Abstract][Full Text] [Related]
6. Allosteric interactions between the oxytocin receptor and the β2-adrenergic receptor in the modulation of ERK1/2 activation are mediated by heterodimerization.
Wrzal PK; Devost D; Pétrin D; Goupil E; Iorio-Morin C; Laporte SA; Zingg HH; Hébert TE
Cell Signal; 2012 Jan; 24(1):342-50. PubMed ID: 21963428
[TBL] [Abstract][Full Text] [Related]
7. The third intracellular loop of alpha 2-adrenergic receptors determines subtype specificity of arrestin interaction.
DeGraff JL; Gurevich VV; Benovic JL
J Biol Chem; 2002 Nov; 277(45):43247-52. PubMed ID: 12205092
[TBL] [Abstract][Full Text] [Related]
8. Rab8 interacts with distinct motifs in alpha2B- and beta2-adrenergic receptors and differentially modulates their transport.
Dong C; Yang L; Zhang X; Gu H; Lam ML; Claycomb WC; Xia H; Wu G
J Biol Chem; 2010 Jun; 285(26):20369-80. PubMed ID: 20424170
[TBL] [Abstract][Full Text] [Related]
9. NF-κB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression.
Wang R; Zhang M; Zhou W; Ly PT; Cai F; Song W
J Neurochem; 2011 Mar; 116(6):1160-70. PubMed ID: 21210816
[TBL] [Abstract][Full Text] [Related]
10. Functional interactions between the oxytocin receptor and the β2-adrenergic receptor: implications for ERK1/2 activation in human myometrial cells.
Wrzal PK; Goupil E; Laporte SA; Hébert TE; Zingg HH
Cell Signal; 2012 Jan; 24(1):333-41. PubMed ID: 21964067
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the amyloid precursor like protein 1 with the alpha2A-adrenergic receptor increases agonist-mediated inhibition of adenylate cyclase.
Weber B; Schaper C; Scholz J; Bein B; Rodde C; H Tonner P
Cell Signal; 2006 Oct; 18(10):1748-57. PubMed ID: 16531006
[TBL] [Abstract][Full Text] [Related]
12. Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function.
Contu VR; Kotake Y; Toyama T; Okuda K; Miyara M; Sakamoto S; Samizo S; Sanoh S; Kumagai Y; Ohta S
J Neurochem; 2014 Sep; 130(6):826-38. PubMed ID: 24832624
[TBL] [Abstract][Full Text] [Related]
13. UCH-L1 inhibitor LDN-57444 hampers mouse oocyte maturation by regulating oxidative stress and mitochondrial function and reducing ERK1/2 expression.
Yuan P; Zhou L; Zhang X; Yao L; Ning J; Han X; Ming C; Zhao Y; Zhang L
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33030206
[TBL] [Abstract][Full Text] [Related]
14. Epitope-tagged receptor knock-in mice reveal that differential desensitization of alpha2-adrenergic responses is because of ligand-selective internalization.
Lu R; Li Y; Zhang Y; Chen Y; Shields AD; Winder DG; Angelotti T; Jiao K; Limbird LE; Zhou Y; Wang Q
J Biol Chem; 2009 May; 284(19):13233-43. PubMed ID: 19276088
[TBL] [Abstract][Full Text] [Related]
15. The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation.
Perez-Aso M; Segura V; Montó F; Barettino D; Noguera MA; Milligan G; D'Ocon P
Biochim Biophys Acta; 2013 Oct; 1833(10):2322-33. PubMed ID: 23797059
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin Carboxyl Terminal Hydrolase L1 Attenuates TNF-α-Mediated Vascular Smooth Muscle Cell Migration Through Suppression of NF-κB Activation.
Gao X; Wu L; Wang K; Zhou X; Duan M; Wang X; Zhang Z; Liu X
Int Heart J; 2018 Nov; 59(6):1409-1415. PubMed ID: 30305579
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of mitogen-activated protein kinase by G protein-coupled alpha(2)-adrenergic receptors does not require agonist-elicited endocytosis.
Schramm NL; Limbird LE
J Biol Chem; 1999 Aug; 274(35):24935-40. PubMed ID: 10455169
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease-associated mutations in α-synuclein and UCH-L1 inhibit the unconventional secretion of UCH-L1.
Konya C; Hatanaka Y; Fujiwara Y; Uchida K; Nagai Y; Wada K; Kabuta T
Neurochem Int; 2011 Aug; 59(2):251-8. PubMed ID: 21693148
[TBL] [Abstract][Full Text] [Related]
19. UCH-L1 promotes invasion of breast cancer cells through activating Akt signaling pathway.
Luo Y; He J; Yang C; Orange M; Ren X; Blair N; Tan T; Yang JM; Zhu H
J Cell Biochem; 2018 Jan; 119(1):691-700. PubMed ID: 28636190
[TBL] [Abstract][Full Text] [Related]
20. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
